Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans H Jamshed, RA Beyl, DL Della Manna, ES Yang, E Ravussin, ... Nutrients 11 (6), 1234, 2019 | 574 | 2019 |
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition LR Ferguson, H Chen, AR Collins, M Connell, G Damia, S Dasgupta, ... Seminars in cancer biology 35, S5-S24, 2015 | 368 | 2015 |
TBCRC 048: phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes NM Tung, ME Robson, S Ventz, CA Santa-Maria, R Nanda, PK Marcom, ... Journal of Clinical Oncology 38 (36), 4274-4282, 2020 | 337 | 2020 |
Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 310 | 2015 |
The intersection between DNA damage response and cell death pathways S Nowsheen, ES Yang Experimental oncology 34 (3), 243, 2012 | 305 | 2012 |
Beyond DNA repair: additional functions of PARP-1 in cancer AN Weaver, ES Yang Frontiers in oncology 3, 290, 2013 | 261 | 2013 |
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis AM De Marzo, VL Marchi, ES Yang, R Veeraswamy, X Lin, WG Nelson Cancer research 59 (16), 3855-3860, 1999 | 233 | 1999 |
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm ES Yang, KL Burnstein Journal of Biological Chemistry 278 (47), 46862-46868, 2003 | 185 | 2003 |
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy L Moretti, ES Yang, KW Kim, B Lu Drug Resistance Updates 10 (4-5), 135-143, 2007 | 159 | 2007 |
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models PL Garcia, AL Miller, KM Kreitzburg, LN Council, TL Gamblin, JD Christein, ... Oncogene 35 (7), 833-845, 2016 | 150 | 2016 |
Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells L Li, H Wang, ES Yang, CL Arteaga, F Xia Cancer research 68 (22), 9141-9146, 2008 | 142 | 2008 |
PARP-1: friend or foe of DNA damage and repair in tumorigenesis? AF Swindall, JA Stanley, ES Yang Cancers 5 (3), 943-958, 2013 | 141 | 2013 |
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study MA Deeley, A Chen, R Datteri, JH Noble, AJ Cmelak, EF Donnelly, ... Physics in Medicine & Biology 56 (14), 4557, 2011 | 139 | 2011 |
Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells S Nowsheen, T Cooper, JA Stanley, ES Yang Public Library of Science 7 (10), e46614, 2012 | 125 | 2012 |
Current and emerging clinical applications of multispectral optoacoustic tomography (MSOT) in oncology LR McNally, M Mezera, DE Morgan, PJ Frederick, ES Yang, IE Eltoum, ... Clinical cancer research 22 (14), 3432-3439, 2016 | 108 | 2016 |
Increasing racial and ethnic diversity in cancer clinical trials: an American Society of Clinical Oncology and Association of Community Cancer Centers joint research statement RA Oyer, P Hurley, L Boehmer, SS Bruinooge, K Levit, N Barrett, ... Journal of Clinical Oncology 40 (19), 2163-2171, 2022 | 103 | 2022 |
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy S Bastola, MS Pavlyukov, D Yamashita, S Ghosh, H Cho, N Kagaya, ... Nature communications 11 (1), 4660, 2020 | 99 | 2020 |
The poly (ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy S Nowsheen, JA Bonner, ES Yang Radiotherapy and Oncology 99 (3), 331-338, 2011 | 94 | 2011 |
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of≥ 3 cm R Jacob, F Turley, DT Redden, S Saddekni, AKA Aal, K Keene, E Yang, ... Hpb 17 (2), 140-149, 2015 | 93 | 2015 |
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors AL Miller, SC Fehling, PL Garcia, TL Gamblin, LN Council, ... EBioMedicine 44, 419-430, 2019 | 91 | 2019 |